Drug Database
Back to search

Netherlands· NL-b0c9787dc8c8

Dabigatran etexilaat Alembic 75 mg harde capsules

A dabigatran etexilate product containing dabigatranetexilaatmesilaat, registered in Netherlands by Alembic Pharmaceuticals Europe Limited. The same ATC class is registered in 16 of our 19 countries.

ATC B01AE07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDabigatran etexilaat Alembic 75 mg ha…ATCB01AE07REGISTER NO.NL-b0c9787dc8c8PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dabigatranetexilaatmesilaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dabigatran etexilate is registered in 16 of 19 countries.

Countries holding a registration under ATC B01AE07 (dabigatran etexilate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search dabigatran etexilate products by name

Dabigatran etexilate · ATC B01AE07

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dabigatran etexilate costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Dabigatran etexilate · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.16
  • IT Italy$2.17
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DABIGATRANETEXILAATMESILAAT
Manufacturer
Alembic Pharmaceuticals Europe Limited
Country
Netherlands (NL)
ATC code
B01AE07
ATC class
Dabigatran etexilate
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    135106

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

47 interactions on record for dabigatran etexilate.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dabigatran etexilate against other medicinesHow interaction checks work

Dabigatran etexilate · interactions on record

47 records

47 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under B01AE07

Dabigatran etexilate, as other registers publish it.

All dabigatran etexilate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b8e15780-2f18-4e3f-aef8-ad69a5d2556f
GET /v1/drugs/b8e15780-2f18-4e3f-aef8-ad69a5d2556f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h135106_smpc.pdf",
  "strength": null,
  "atc_label": "Dabigatran Etexilate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg135106",
  "excipients": [
    "AMMONIA (E 527)",
    "CARRAGEENAN (E 407)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "HYPROMELLOSEFTALAAT",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMCHLORIDE (E 508)",
    "KALIUMHYDROXIDE (E 525)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "WIJNSTEENZUUR, (L (+) Vorm) (E 334)",
    "ZWARTE INKT"
  ],
  "substances": [
    "DABIGATRANETEXILAATMESILAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h135106.pdf",
  "authorised_at": "2026/08/18",
  "procedure_number": "IS/H/0704/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "135106",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about dabigatran etexilate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console